Background
==========

The prevalence rate of psychosocial problems is higher among patients with chronic somatic diseases than among the general population \[[@B1]-[@B4]\]. Problems like depression or distress may hamper the ability to manage a chronic condition \[[@B5]\]. A reciprocal relationship has been suggested: emotional distress may interfere with control over the disease, and at the same time, poor control over the disease can lead to emotional distress. Persistent negative feelings have implications for adherence to medication and lifestyle regiments, motivation, self-efficacy and problem solving \[[@B6],[@B7]\]. Patients therefore face not only the day-to-day medical management, but also the challenge to deal with their emotions and problems of daily functioning in order to remain in control of their illness \[[@B6],[@B8]\]. To improve the outcomes of chronic care, Lorig and Holman argue that three self-management tasks should be addressed in primary care: medical management, emotional management and role management \[[@B8]\]. However, Dutch guidelines for the care of chronic diseases like type 2 diabetes mellitus primarily focus on medical and lifestyle management \[[@B9],[@B10]\]. This seems too narrow a focus, as there is also room for improvement in the detection and treatment of emotional problems in the chronically ill \[[@B4],[@B11],[@B12]\].

Our study intends to facilitate a shift towards a chronic care approach that combines attention to both biomedical and psychosocial aspects. We believe that equipping practice nurses (PNs) with the ability to provide this might be an effective way to realise such a biopsychosocial approach in chronic care \[[@B13]\]. PNs in the Dutch primary care setting see patients on a regular basis, as they have the task of providing routine check-ups \[[@B14]\]. Since diabetes patients were the first to be cared for by PNs, we aim to integrate an existing nurse-led minimal psychological intervention (MPI) in the diabetes follow-up care by PNs. The nurse-led MPI has proved to be effective in supporting the self-management skills of diabetes and COPD patients with minor to moderate depression \[[@B15]-[@B18]\].

The MPI can only be adopted by PNs if a detection method is added that enables PNs to distinguish between patients who are active self-managers, patients who would benefit from the psychosocial support, and patients who need more specialised psychosocial diagnostics or treatment. We call the resulting stepped approach to detection and treatment 'Self-Management Support' (SMS). In addition to adapting the MPI to become SMS, we need to arrange for a training course with booster sessions, and ensure the allocation of time and organisational support to enable the PNs to adopt SMS in their current practice. For a thorough understanding of the effectiveness of SMS, the facilitators and barriers to its implementation in routine care need to be taken into account. Therefore, we want to start a hybrid effectiveness--implementation trial to examine the effectiveness of SMS in terms of patient outcomes, and focus on implementation outcomes.

Aim
---

The aim of our study is to evaluate the process and effectiveness of SMS implemented as an integral part of the care for patients with type 2 diabetes mellitus provided by PNs. We will simultaneously address the following research questions:

1\. *What is the uptake of the SMS programme by the practice nurses, and what barriers hamper the implementation of SMS in routine primary care?* (Study of the implementation strategies for SMS.)

2\. *What is the effectiveness of SMS in terms of daily functioning, emotional health status, social participation, self-management behaviour, and health care use by patients with type 2 diabetes?* (Study of the SMS clinical intervention.)

The effectiveness of SMS (question 2) will be considered while taking the barriers to the implementation process (question 1) into account.

Methods/Design
==============

In our study, we will use a hybrid effectiveness--implementation design to focus on implementation issues and the effectiveness of SMS at the same time. Curran and colleagues have presented a continuum of three types of such hybrid effectiveness--implementation (E-I) study designs \[[@B19]\], ranging from effectiveness research with minimal implementation strategies (type 1) to designs where effectiveness and implementation are equally balanced (type 2) and an implementation approach with minimal focus on effectiveness outcomes (type 3). We will examine the effects of SMS on patient outcomes and simultaneously focus on implementation outcomes, hence it is a type 2 hybrid E-I study design.

Below, we first describe our implementation strategies (intervention) and then explain our evaluation methods regarding the implementation and effects of SMS in routine care (evaluation).

Intervention
------------

In a previous study, the nurse-led minimal psychological intervention (MPI) was carried out by trained research nurses \[[@B20]\]. In our present study, practice nurses who provide diabetes care will have to adopt the MPI in their current practice. This required changes with regard to the clinical intervention as well as the organisational context in which the intervention will be integrated \[[@B21]\]. This section explains the steps that will be taken to implement the resulting SMS in routine diabetes care.

### Implementation strategy 1: adaptation of clinical intervention

The nurse-led MPI has been altered from a 'research object' to an intervention that can be systematically embedded in routine primary care. Adaptations were needed regarding the target group, providers, detection of eligible patients and self-management support. The shift from MPI to SMS is summarised in Table [1](#T1){ref-type="table"}.

###### 

The SMS approach contrasted with the original MPI

                                         **MPI**                                                                                                 **SMS**
  -------------------------------------- ------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------
  Target group                           Chronic patients with mild or non-severe major depression                                               Chronic patients with emotional distress and problems of daily functioning
  Providers                              Research nurses not involved in usual care                                                              Practice nurses providing usual chronic care
  Diagnostic approach                    For research purposes. Using an extensive diagnostic interview, following strict psychiatric criteria   As part of daily care. Using simple tools, following a stepped care approach that fits the primary care setting
  Self-management support intervention   1\. cognitive therapy (reattribution)                                                                   1\. problem solving
  2\. problem solving                    2\. cognitive therapy (reattribution)                                                                   

#### Target group

The original effective nurse-led MPI was provided specifically to patients with a diagnosis of depression, whereas a wide range of psychological and social problems occur in a routine primary care setting. What primarily matters in daily practice is to what extent patients experience problems of daily functioning \[[@B12]\]. SMS was therefore designed for chronic patients who encounter problems of daily functioning and emotional distress.

#### Providers

Instead of research nurses providing the intervention as an add-on to usual care, SMS will be integrated in usual care provided by PNs. PNs work in general practice under supervision of a GP. They see type 2 diabetes patients every 3 months for a diabetes check-up. SMS is to become an integral part of these check-ups.

#### Detection procedure

The diagnostic procedure that was used to recruit patients for the study to evaluate the original MPI is not feasible in routine primary care: it was limited to depression, and included an extensive and time-consuming diagnostic interview (the Mini International Neuropsychiatry Interview) to confirm a diagnosis of depression according to psychiatric criteria. For SMS, PNs will have to decide during routine diabetes check-ups whether watchful waiting, offering psychosocial self-management support or a referral to the GP because of symptoms of mental health problems is most appropriate. Therefore, we have introduced a stepped approach that allows interventions not sooner or more intense than necessary and not later or less intense than required. The approach is as follows. During each regular diabetes check-up, PNs will explore whether the patient is experiencing problems in daily life. Then they verbally administer the 'Daily Functioning Thermometer' (DFT), a visual analogue scale to rate the overall burden of diabetes. (See the Measurements section below for more information about the instruments.) Practice nurses will also verbally administer the 3-item Distress Screener (DS), a quick-scan instrument for emotional distress and an indicator of potential underlying severe mental health problems \[[@B22]\]. Patients with DS \> 3 will be asked to complete the Four-Dimensional Symptom Questionnaire (4DSQ) \[[@B23]\] immediately after the consultation. This self-report measure is widely used in Dutch primary care to distinguish non-specific general distress from depression, anxiety and somatisation. Scoring the 50 items of the 4DSQ should take 5--10 minutes The completed 4DSQ will be returned to the PN, who will score the 4DSQ using a scoring form. Patient's scores on the 4DSQ will distinguish between mild, moderate and severe mental health problems. Patients who experience problems of daily functioning (DFT \> 4) and emotional health problems (DS \> 3 combined with moderate scores on subscales of the 4DSQ) will receive self-management support from the PN. If a patient has only 'mild' scores on the 4DSQ, the PNs will opt for watchful waiting. The same option will be used for patients with moderate scores on the 4DSQ who do not report problems of daily functioning due to diabetes (DFT ≤ 4). These patients will be informed by telephone that there is as yet no indication for extra consultations. Patients with a 'severe' score on at least one of the subscales will be referred to the GP. The detection protocol is summarised in Table [2](#T2){ref-type="table"}.

###### 

Detection protocol

                               **DFT** ≤ **4**                               **DFT \> 4**
  ---------------------------- --------------------------------------------- ---------------------------
  DS ≤ 3                       No indication                                 Watchful waiting
  DS \> 3                      On the basis of the 4DSQ:                     On the basis of the 4DSQ:
  Mild: watchful waiting       Mild: watchful waiting                        
  Moderate: watchful waiting   **Moderate: self-management support by PN**   
  Severe: referral to GP       Severe: referral to GP                        

#### Self-management support programme

The self-management support by the PN will be provided during extra 20-minutes consultations. Its aim is to teach patients to take responsibility for the day-to-day management of their diabetes and its consequences. This self-management support is based on the MPI. The intervention strategy has been derived from principles of learning theory and has been described elsewhere \[[@B24]\]. PNs will help patients to define problems and solutions themselves, applying the techniques of problem-solving and reattribution. Problem-solving consists of 7 stages that efficiently address psychosocial problems and their possible solutions \[[@B25]\]. It starts by creating a link between emotional symptoms and problems, and explaining the rationale of the treatment: resolution of the problems may lead to resolution of the symptoms (step 1).

Step 2 involves clarifying and defining the problem. The third step is to set achievable goals. Once an achievable goal has been set, the patient will be asked to brainstorm about all potential solutions (step 4). Step 5 involves considering the pros and cons and selecting a preferred solution. In step 6, the solution will be implemented in daily life, and step 7 involves evaluating the progress. The problem-solving approach can easily be understood by patients and can also easily be taught to practice nurses \[[@B25]\]. Patients with strong emotional involvement will be supported using the reattribution technique. This starts by exploring and defining the patient's problem, after which the patient is challenged to link cognitions to behaviour. To this end, patients may keep a diary to record thoughts, behaviours and related feelings. After possibilities to alter specific behaviours have been explored, an action plan will be formulated indicating how the goals can be achieved \[[@B20]\]. If specific problems appear to be persistent and serious over time, action will be undertaken to provide more specialised care. PNs are instructed to refer these patients to the GP.

In the original MPI, the cognitive approach appeared to benefit more highly educated patients more than lower educated ones \[[@B18]\]. The SMS will be implemented in a region in the south of the Netherlands that is characterised by relatively low socio-economic status \[[@B26]\], so in order to increase the benefit for patients with low socio-economic status, we will put greater emphasis on the problem-solving technique during the training of PNs.

A flowchart of SMS is presented in Figure [1](#F1){ref-type="fig"}.

![Flowchart for SMS intervention.](1471-2296-14-77-1){#F1}

### Implementation strategy 2: involvement of regional GP organisation

SMS will be implemented in one region in the south of the Netherlands. A group of 77 general practices (103 GPs) in the region, who collaborate in a GP organisation, was involved from the beginning of the SMS project, and they have prioritised the integration of SMS in the care for type 2 diabetes patients. The GPs are responsible for about 16,000 patients with type 2 diabetes mellitus. The region is characterised by relatively low socio-economic status, health status and life expectancy and substantial ageing of the population \[[@B26],[@B27]\]. Based on earlier research findings we estimate that as many as 2400 patients with type 2 diabetes mellitus (15%) may suffer from emotional distress accompanied by problems of daily functioning \[[@B28]\].

### Implementation strategy 3: financial support

The reimbursement of diabetes care in the Netherlands is regulated by means of diagnosis-treatment combinations (DTC), a Dutch variant of the Diagnosis Related Groups \[[@B29]\]. For each care group, health insurers' purchase integrated care by negotiating a fixed price per patient per year. The elements of care with corresponding tariffs are defined in a shared care protocol. This is driven by the Dutch 'care standard' for diabetes \[[@B9]\], which is based on existing guidelines, protocols and performance indicators. During the study, a health insurance company will reimburse the extra time spent on SMS by practice nurses and GPs. The reimbursement will be integrated in the DTC for diabetes care.

### Implementation strategy 4: training

The PNs in the intervention group will be trained to carry out SMS in three 8-hour training sessions. The training programme is based on a nurses' training course that has been shown to be feasible, attractive and successful. PNs learn how to help patients identify their problems and set achievable goals \[[@B24]\]. The training programme will also focus on exploration skills. PNs will learn to use instruments to establish the severity of psychosocial problems in a stepped approach (first DFT and DS, and if appropriate further exploration using 4DSQ). The training sessions will take place in small groups, to facilitate active participation of the PNs, for example by role-play. These three training sessions will be followed up by booster sessions and telephone consultations, whose frequency will depend on the PNs' needs. Booster sessions will be used to maintain and improve the PNs' SMS skills. PNs will make audiotapes during consultations, which will be reflected on during booster sessions.

### Implementation strategy 5: registration system for SMS

SMS will be integrated in the registration system that GPs and PNs use for diabetes care. The steps to be taken during the detection phase of SMS as well as the different stages of the self-management support by the PN are displayed in the regular registration system. PNs will record how patients rate their burden of diabetes (DFT), as well as their scores on the distress screener (DS). This information will be displayed at the next diabetes check-up. The system also helps PNs compute the outcomes of the 50-item Four-Dimensional Symptom Questionnaire (4DSQ). The PNs will also record the self-management support steps that are taken during each consultation, and the patients' action plans.

Evaluation of the implementation process
----------------------------------------

### Design

A process evaluation will be done to analyse the facilitators and barriers regarding integration of SMS in routine care. We will gather quantitative and qualitative data about the intervention as an integral part of the routine diabetes care, as well as about the health professionals (PNs and GPs) and patients, and the impact of SMS on the practice organisation and the community \[[@B30]\]. How SMS has been implemented and received by the participants will be measured by means of the following concepts, as recommended by Saunders and colleagues \[[@B31]\]: fidelity, dose delivered, dose received, reach, recruitment and context. In addition, the costs of implementing SMS in routine care will be assessed. The process evaluation will include formative evaluation with respect to the new components of the clinical intervention, as these aspects may need to be refined or optimised to make them fit the local setting.

### Variables and measurements

* Fidelity* refers to the extent to which SMS has been implemented as planned. At each diabetes consultation, the PNs will record which steps of the SMS protocol have been carried out. The outcomes on the DS, DFT and 4DSQ, the choices that have been made regarding further treatment and the patients' action plans will also be recorded. The registration system also offers room for comments. PNs will be asked to give an explanation if they deviate from the SMS protocol.

*Dose delivered* is measured as the number of components of SMS per patient that have been carried out as intended. Data will be derived from the registration system.

*Dose received* includes two components: *satisfaction* and *exposure.*

Exposure refers to the extent to which participants (patients and health professionals) are actively engaged with the SMS programme and use the tools of SMS in daily practice. Engagement and satisfaction of participants will be measured among the providers (PNs and GPs) and among the patients.

PNs will be asked to complete an evaluation form after the training sessions, with questions about the clarity of wording of the components of the training course. With regard to the integration of SMS in routine diabetes consultations, issues discussed with PNs during booster sessions will be recorded during the follow-up period. This will provide qualitative information about the barriers and facilitators that PNs may experience. At the end of the follow-up period (one year after the SMS training course), we will develop a questionnaire including all the barriers and facilitators that have been discussed during the booster sessions. PNs will be asked to individually rate all these issues.

The engagement and satisfaction of GPs will be evaluated by means of self-administered questionnaires. All participating GPs from the intervention arm will be asked about their involvement in the SMS programme and their views on the impact of SMS for their practice.

How patients experience being involved in the SMS programme will be explored in detail by holding semi-structured interviews with a purposive sample of patients who have received the SMS from their PN. These interviews will be held during the follow-up period. The topics include patients' experiences with the detection phase of SMS, the self-management support, the opportunities for and barriers to the implementation of their action plans in daily life, and their suggestions for improvement of the SMS. Interviews with patients will be audio-taped and transcribed verbatim.

*Recruitment* refers to the way we have approached and invited the PNs and GPs to become involved in the project to implement and evaluate SMS.

*Reach* refers to the participation rate and will be measured as the number of GPs and PNs who actually participated.

*Context* refers to the factors relating to the practice, the community, the social/political context, or other situational issues that affect either the implementation of SMS or its outcomes. To examine context issues in terms of the implementation and effect of SMS, we will draw up the minutes of meetings with the regional care group of general practitioners, the health insurer and our research team.

### Cost evaluation

We will measure the direct costs of SMS. In addition to the training and booster sessions, these will include the time to integrate SMS in routine diabetes consultations. PNs will record the time they spend on each stage of the stepped SMS approach.

### Data analysis

Data of the implementation study will be analysed by means of descriptive statistics.

The qualitative interviews with patients will be analysed by interpretative phenomenological analysis, a framework that can be used to develop in-depth descriptions of patients' experiences. The purpose is to explore the patients' perceptions of what is important in relation to SMS. We will abstract themes and cluster them for each case \[[@B32]\]. Abstracting and clustering of the themes will be done independently by two researchers.

Clinical effect evaluation
--------------------------

### Design

The effect evaluation of SMS involves a pragmatic 2-armed cluster-randomised controlled trial (cluster-RCT) with PNs as the unit of randomisation. Allocation concealment will be achieved by having an independent experienced research assistant perform a blockwise randomisation using a random number seed computer program. PNs (n = 46) will be assigned to an intervention group or control group at an allocation ratio of 1:1, after stratification into PNs working alone in a practice, PNs working in a team and PNs working in different practices. PNs working in the same general practice will be randomised to the same trial arm.

PNs in the intervention arm will be trained to apply SMS in addition to the usual care, which consists of 3-monthly diabetes check-ups according to the current guidelines \[[@B10]\]. PNs in the control arm will be instructed to provide usual care.

Patients with emotional distress and problems of daily functioning will be included in the effect evaluation. To maintain the balance between the intervention and control groups, a screening procedure will be carried out by the research centre. A self-administered postal questionnaire will be used to detect eligible patients.

Approval for this study has been obtained from the Medical Ethics Committee of Maastricht University/University Hospital Maastricht.

### Sample size calculation

Assuming an alpha of 0.05 and a beta of 0.90, an improvement in perceived daily functioning (defined as a score less than or equal to 4 on the Daily Functioning Thermometer (DFT), our primary outcome) at T12 occurring in 20% of the patients in the intervention group versus 5% of those in the control group requires at least a net number of 116 patients per arm (N = 232; 5 patients per practice nurse). It will be necessary to take account of a possible dependence between observations on patients of the same practice nurse. The intra-class correlation coefficient (ICC) is assumed to be 0.04, a median value for cluster-RCTs in the primary care setting \[[@B33]\]. Assuming a 30% loss to follow-up \[[@B17]\] we need to recruit at least 331 patients (8 per PN). Since participation in the screening procedure will not necessarily mean that patients also give informed consent for the effect evaluation, 10 consecutive patients for each PN will be invited to participate in the effect evaluation (N = 460).

### Patient recruitment

All patients with a clinically established diagnosis of type 2 diabetes mellitus who are able to read and write Dutch will be sent a letter by their GP, explaining SMS and asking for informed consent to participate. Patients will receive this letter six weeks before a planned diabetes consultation with their PN. The enclosed screening questionnaire will contain the same instruments that PNs in the intervention group are going to use to detect whether patients are eligible for the self-management support, i.e. the 'Daily Functioning Thermometer' (DFT) and the 3-item Distress Screener (DS) \[[@B22]\]. For more information about these instruments, see the section on Measurements below. Patients will be asked to return the completed questionnaire to the research centre and give informed consent for their data to be used for recruitment if they are found to be at risk. For each practice nurse, 10 consecutive patients with scores of DFT \>4 and DS \>3 will be asked to participate in the study and to give informed consent for the follow-up measurements. To prevent bias, PNs will not be notified about the outcomes of the recruitment procedure.

A flowchart of the trial is shown in Figure [2](#F2){ref-type="fig"}.

![**Flowchart for SMS trial.** \* DFT = Daily Functioning Thermometer. \*\* DS = Distress Screener.](1471-2296-14-77-2){#F2}

### Measurements

To assess the effectiveness of SMS, follow-up measurements will be carried out at baseline and 4 and 12 months after inclusion. Table [3](#T3){ref-type="table"} provides an overview of the measures of the effect evaluation and the times of assessment.

###### 

Effect evaluation: outcome measures and time of assessment

  **Concept**                                                           **Measurement**                        **Items**   **Moment in time**               
  --------------------------------------------------------------------- ------------------------------------- ----------- -------------------- ------- ---- ------
  *Primary outcome*                                                                                                                                         
  Daily functioning                                                     DFT                                        1                             \*     \*   *\**
  *Secondary outcomes*                                                                                                                                      
  Diabetes-related emotional distress                                   PAID                                      20                             \*     \*   *\**
  Mental health problems                                                PSYCHLOPS                                  9             \*^2^          \*^1^   \*   *\**
  4DSQ                                                                  50                                                                       \*     \*  
  Quality of life                                                       SF-12                                     12                             \*     \*   *\**
  Participation and autonomy                                            IPA                                     32 + 9                           \*     \*   *\**
  Job performance                                                       SF-HLQ                                     5                             \*     \*    \*
  Self-management knowledge and behaviour                               PIH-NL                                    12                             \*     \*   *\**
  General self-efficacy                                                 GSES-12                                   12                             \*     \*    \*
  Control over the disease                                              Average blood glucose level (HbA1c)        1               \*                          
  Health care use                                                                                                  5                             \*     \*    \*
  *Covariates*                                                                                                                                              
  Patient demographics                                                  Sex                                        1                             \*            
  Age                                                                   1                                                          \*                       
  Year of diagnosis                                                     1                                                          \*                       
  Treatment of diabetes                                                 1                                                          \*                       
  Marital status                                                        1                                                          \*                       
  Education                                                             1                                                          \*                       
  Practice nurse demographics                                           Age                                        1                             \*            
  Training                                                              1                                                          \*                       
  Type of general practice(s) (one GP, two GPs, group, health centre)   1                                                          \*                       

1 Only patients in intervention arm. Risk of contamination.

2 Only eligible patients (Distress Screener \> 3).

\* = measuring moment.

#### Background variables

Patient variables that will be reported are sex, age, year of diagnosis, treatment of diabetes (insulin therapy or tablets), marital status and education. Furthermore, we will record the age of the PNs, the number of PNs for diabetes management working in a general practice, as well as the educational background of the PNs.

#### Primary outcome measure

The primary outcome will be daily functioning as measured by means of the Daily Functioning Thermometer (DFT). This is a visual analogue scale (VAS) on which patients can rate the overall burden of diabetes on their daily functioning by indicating a position along a continuous vertical 100 mm line between 0 ('no burden at all') and 10 ('extreme burden'). The VAS score is determined by measuring the distance to the point marked by the patient, in millimetres. The DFT is comparable to the Distress Thermometer (DT), an easily understood, valid and feasible self-report measure of distress used among various groups of cancer patients \[[@B34]\]. A cut-off score of 4 has been chosen to differentiate between patients who could benefit from self-management support by the PN (DFT \> 4) and patients who have apparently found a satisfactory way to live with the consequences of their diabetes (DFT ≤ 4). A pilot study among 7 patients with type 2 diabetes mellitus confirmed the face validity of the DFT.

#### Secondary outcome measures

Three instruments will assess patients' emotional health status.

Diabetes-related emotional distress will be measured by means of the Problem Areas in Diabetes questionnaire (PAID). This 20-item scale (with five-point Likert scales) describes common problematic situations for diabetes patients, each representing a unique area of diabetes-specific emotional distress. The sum of the scores for the 20 items is multiplied by 1.25 to get a final score between 0 and 100. The Dutch PAID has good internal consistency and validity \[[@B35]-[@B37]\].

The Four-Dimensional Symptom Questionnaire (4DSQ) will be used to measure the presence and severity of mental health problems \[[@B23]\]. The levels of distress (16 items), depression (6 items), anxiety (12 items) and somatisation (16 items) will be assessed. The reference period is 'the past week'. The item scores are summated to obtain scale scores. The 4DSQ has been found to be a valid self-reported questionnaire in the primary care setting \[[@B23]\]. For a more qualitative evaluation of emotional problems that patients experience, we will use the Psychological Outcome Profiles (PSYCHLOPS). The PSYCHLOPS asks patients to describe and score their own emotional health problems. It is a validated patient-generated measure with pre-therapy, during-therapy and post-therapy versions. The instrument is intended to measure individual changes. It is responsive to change and is internally consistent \[[@B38]\].

Both PSYCHLOPS and 4DSQ explicitly expect patients to define and rate their emotional health problems. An increased awareness about their emotional problems of daily functioning could influence the issues discussed during the diabetes consultation, which could result in reduced contrast between the two groups. We will not use the 4DSQ and the PSYCHLOPS in the control group at T0, as the timing of the baseline measurement is just before a diabetes consultation, whereas the assessment at T4 is further removed from a diabetes consultation. Inclusion of the PSYCHLOPS and 4DSQ at both T4 and at the end of the follow-up period (T12) will provide insight into individual changes. In the intervention group, inclusion of the PSYCHLOPS at baseline will provide valuable information about the patients' individual emotional problems. The 4DSQ does not need to be included in the baseline measurement as it is already part of the SMS intervention.

Quality of life, i.e. functional health and well-being from the patient's point of view, will be measured by means of the 12-item Short-Form Health Survey (SF-12), a validated subset of the generic health status questionnaire SF-36 \[[@B39],[@B40]\]. Data will be summarised in 2 scales: a physical component summary (PCS) and a mental component summary (MCS).

Participation and autonomy will be measured by means of the Impact on Participation and Autonomy (IPA) questionnaire. The IPA has proved to be valid, reliable and responsive to change \[[@B41]\]. Thirty-two items (five-point Likert scales) cover five domains of participation: 'autonomy indoors', 'family role', 'autonomy outdoors', 'social life and relationships' and 'work and education'. A score for each subscale will be calculated. In addition, 9 items will evaluate the extent to which limitations are experienced as problematic: 'no problems', 'minor problems' or 'major problems'. These items will be scored separately \[[@B42]\].

Five items from the Short-Form Health and Labour Questionnaire (SF-HLQ) will be used to measure difficulties of job performance due to health problems. The SF-HLQ is a generic and validated measurement to collect data about productivity loss relating to health problems \[[@B43]\].

Patients' self-management knowledge and behaviours regarding their diabetes will be measured by the Partners in Health (PIH) scale \[[@B44]\]. This scale reliably and validly measures aspects of patient progress within a self-management programme for a chronic condition. We will use the Dutch version (PIH-NL). The 12 items (0--8 Likert scales with 0 indicating high self-management and 8 low self-management) cover four domains of patients' competency in relation to the self-management of their chronic condition (knowledge, coping, management of condition and adherence to treatment).

The General Self-Efficacy Scale (GSES-12) will be used to assess the patients' belief in their ability to organise and engage in certain behaviours. The sum score of the 12 items (five-point Likert scales) reflects an internally consistent and stable unidimensional construct of general self-efficacy \[[@B45],[@B46]\].

At each diabetes consultation, the blood glucose level over the past 2 to 3 months (HbA1c) will be measured and recorded in the registration system.

The effect of SMS on patients' health care utilisation refers to individual numbers of visits to the general practice, specialist referrals and admissions, mental health care consultations, use of home care and hours of paid and unpaid household help. Patients will record their health care use retrospectively (over the last month) in the patient questionnaires administered at baseline and after 4 and 12 months. Data about referrals to the GP, and the number of contacts with the general practice will be collected from the GP's registration system.

### Data analysis of the effect evaluation

The effectiveness of SMS will be assessed by intention-to-treat analyses. The comparability of patients in the intervention and control groups regarding baseline characteristics and demographics will be described and tested for significant differences (t-tests and Chi-square tests). The average changes in DFT score will be calculated, as well as the number of patients that have DFT ≤4 after receiving SMS (T4 and T12). Separate scores will be calculated for the subscales of the secondary outcome measures. Changes in the primary and secondary outcomes between the intervention and control groups will be analysed using multilevel analyses (linear and logistic regression methods) as this will account for intracluster correlation among PNs. Multivariate regression analyses will be used to adjust the results for co-variables such as patient characteristics (age, sex, socio-economic status) and PN characteristics (age, educational background).

Discussion
==========

This paper describes a study protocol to implement and evaluate an evidence-based, nurse-led minimal psychological intervention (MPI) in routine diabetes care in the Dutch primary care setting. The intervention itself has already been found to be an effective and cost-effective method to improve self-management by chronic patients with mild to moderate depression, but its effect was evaluated in a trial with standardised conditions regarding the inclusion of patients, and the care was delivered by research nurses \[[@B20]\]. Both GPs and a health insurer have prioritised the inclusion of the MPI in routine diabetes care, so there was an 'implementation momentum' within the system \[[@B19]\]. Actually making this happen required adaptations to be introduced regarding providers, target group and detection procedure. The new approach has been named Self-Management Support (SMS).

Our hybrid design and its potential
-----------------------------------

The effects of integrating SMS in the routine primary care setting can only be evaluated when it is implemented in the 'real world'; the implementation strategies will be decisive for the success of SMS at the practice and patient levels. The essential adjustments to the intervention with regard to both providers and recipients require further insights into the effectiveness of SMS. An understanding of both the prerequisites of integrating SMS in routine care and the effectiveness of SMS is essential for future planning. In terms of the continuum of design types proposed by Curran and colleagues \[[@B19]\], our study is an example of a type 2 hybrid effectiveness--implementation (E-I) study design. The effects and the implementation process will be evaluated simultaneously.

Curran and colleagues \[[@B19]\] argue that the combination of two study designs in a hybrid study may have the potential to accelerate the translation of research into routine practice. They refer to the dominant approach of translating research into practice that starts with clinical efficacy research, then clinical effectiveness research, and finally implementation research. The potential for rapid integration of research into practice is also apparent in our study. SMS evolved from a joint endeavour of the regional care organisation of general practitioners, the health insurer and the evaluators. The intervention has been developed as a generic approach to support patients' self-management. The outcomes of the implementation and evaluation of SMS will provide a broad perspective on barriers, facilitators and effects of the detection and treatment of psychosocial problems by PNs in chronic care. Hence, if SMS appears to be successfully implemented and has relevant effects, it could in the near future also be applied to patients with other chronic conditions. The shared vision of stakeholders regarding SMS and their involvement in the development and evaluation is expected to facilitate a rapid large-scale integration of SMS in routine care.

Our hybrid design and its methodological challenges
---------------------------------------------------

In hybrid E-I studies, the world of implementation science has to combine with the tradition and vocabulary of researchers from clinical research backgrounds. This implies a complex balance in the design itself between internal validity and factors associated with implementation, but also can be an obstacle to funding and publication \[[@B19],[@B47]\].

Our study involves an additional methodological issue with respect to hybrid design, viz. the new detection method that is introduced in our study to integrate the original MPI in routine care. Its feasibility in routine diabetes consultations is not yet known, and needs to be evaluated as part of our process evaluation. However, an adequate detection method is also a prerequisite for clinical effectiveness of SMS. The methodological issues regarding the detection method are further explained below.

In order to integrate the MPI in the daily care by practice nurses, we had to introduce a new detection method to fit the primary care setting. The MPI has been adapted to become a self-management intervention for patients with problems of daily functioning and emotional distress. As there was no primary care instrument available to detect patients with these psychosocial problems, we have introduced new instruments in the form of the Distress Screener and the Daily Functioning Thermometer, and defined the cut-off criteria. The Distress Screener and the Daily Functioning Thermometer are assumed to be valid for the early detection of patients with emotional distress and problems of daily functioning \[[@B22],[@B34]\]. These instruments will be integrated into the routine diabetes consultations provided by PNs. Our implementation strategies (i.e. providing training, financial support and a registration system) will determine whether PNs are able to integrate the instruments in their daily practice. Evaluation of the implementation process will show what numbers of patients are detected, whether patients with problems of daily functioning (according to the DFT) and with moderate psychological problems (according to the Four-Dimensional Symptom Questionnaire, 4DSQ) are representative of the group of patients that are in need of the self-management support, and to what extent PNs have the skills to integrate the tools in their routine consultations. The feasibility, power and success of our detection method are unknown and will determine the success and feasibility of the whole SMS approach.

The detection method will an integral part of the tasks of the PNs during a routine diabetes consultation. PNs will be given a reasonable degree of freedom in applying the detection method in their consultations, as we use a pragmatic approach without strict internal controls. We aim to avoid interference of research activities with daily practice as much as possible, which has implications for the recruitment of patients for the effect evaluation.

In theory, all diabetes patients of the PNs would be eligible for participation in the effect evaluation of SMS, as the PNs will apply the detection part of SMS in every diabetes consultation. However, we have chosen to limit the effect evaluation to patients with actual problems of daily functioning and emotional distress. This will increase the contrast between the intervention and control groups, so we need to include patients that are likely to be detected during regular care and receive further treatment. We had to set up a researcher-led parallel screening procedure to detect eligible patients from both the intervention and control groups. Based on our pragmatic approach, the conditions for this screening procedure are:

1\. The self-administered screening questionnaire is sent to the patient's home address and includes the instruments that PNs apply during consultation.

2\. The screening does not interfere with daily practice in the control arm. As the DFT and DS consist of simple and generic questions, we do not expect any interference with daily care.

3\. The time interval between the researcher-led screening and the nurse-led detection procedure needs to be limited. We have decided to send the screening questionnaire six weeks before the individual diabetes consultation appointment.

However, we cannot avoid the risk that natural fluctuations in the emotional health status of patients will result in different outcomes on the DFT and DS in the nurse-led detection compared to the researcher-led postal screening. The time interval could become too long, for example if a consultation appointment is cancelled. We thus have to take into account that conclusions based on the researcher-led screening questionnaires will not always correspond to those of the same instruments applied by the PNs during the consultations. As a consequence, a certain number of patients in our study sample will only be exposed to the detection part of SMS, without receiving follow-up treatment, while some patients who are not included in the effect evaluation may receive the self-management support. This may reduce the contrast between the intervention and control arms.

In conclusion, the strength of the clinical effectiveness evaluation in our study greatly depends on two risk factors of our hybrid design:

1\. the extent to which PNs are able to detect patients who need the self-management support; and

2\. the match between the patients who are detected by the researcher-led screening and those detected by the PN.

If PNs in our study would, for any reason, not detect or not treat patients who are recruited for the effect evaluation on the basis of the researcher-led screening, it may become difficult to demonstrate the clinical effectiveness of SMS. Nevertheless, the clinical effectiveness outcomes of SMS integrated in routine care are very important for decisions about future planning and (financial) support for SMS. If we are unable to demonstrate clinical effectiveness of SMS, the speed of translation of the evidence-based intervention into routine care may even be threatened due to the methodological issues of a hybrid effectiveness--implementation design. We will try to minimise the risks by providing training to PNs, followed by booster sessions, using a formative evaluation method that gives us the opportunity to refine the detection procedure, and by a researcher-led screening that closely resembles the detection at the consultation in terms of timing and procedure.
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